Corticotropin is used for promoting new vessel formation in ophthalmic diseases. It was first introduced by Sanofi Aventis Us Llc in its drug Acthar on Approved Prior to Jan 1, 1982. Other drugs containing Corticotropin are Corticotropin, Acth, Purified Cortrophin Gel, Acthar Gel (Autoinjector), Acthar Gel. 6 different companies have introduced drugs containing Corticotropin.

Corticotropin Patents

Given below is the list of patents protecting Corticotropin, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Purified Cortrophin Gel	US11975047	Methods for storing and warming purified corticotropin compositions	Oct 27, 2043	Ani Pharms
Purified Cortrophin Gel	US12102662	Methods for storing and warming purified corticotropin compositions	Oct 27, 2043	Ani Pharms
Purified Cortrophin Gel	US12233105	Methods for storing and warming purified corticotropin compositions	Oct 27, 2043	Ani Pharms
Purified Cortrophin Gel	US12324787	Contactless optical process for identifying objects	Oct 27, 2043	Ani Pharms
Acthar Gel	US11752199	Methods of modulating pericytes	Jul 18, 2041	Mallinckrodt Ireland
Acthar Gel (autoinjector)	US11752199	Methods of modulating pericytes	Jul 18, 2041	Mallinckrodt Ireland

Add above patents to watchlist

Corticotropin's Family Patents

Full family tree

Corticotropin Generic API Manufacturers

Only one generic application has been filed for Corticotropin.

Given below is the list of companies who have filed for Corticotropin generic, along with the locations of their manufacturing plants worldwide.